EMEA (Europe, Middle East and Africa) Over-the-Counter Drug Market Report 2017

August 2017 | 119 pages | ID: ED0F4D66F95EN
QYResearch

Abstracts

In this report, the EMEA Over-the-Counter Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Over-the-Counter Drug for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Over-the-Counter Drug market competition by top manufacturers/players, with Over-the-Counter Drug sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bayer HealthCare
• GSK
• Johnson & Johnson
• Pfizer
• Sanofi
• Abbott
• Achelios Therapeutics
• American Health
• Amgen
• AstraZeneca
• BioGaia
• Bristol-Myers Squibb
• Bukwang Pharmaceutica
• Chr. Hansen
• Daiichi Sankyo
• Dr. Reddy's Laboratories
• Himalaya Drug Company
• Hypermarcas

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Oral
• Topical
• Parenteral

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Over-the-Counter Drug for each application, including

• Dietary supplements
• Gastrointestinal drugs
• Pain medications
• Respiratory drugs

Contents

EMEA (Europe, Middle East and Africa) Over-the-Counter Drug Market Report 2017

1 OVER-THE-COUNTER DRUG OVERVIEW

1.1 Product Overview and Scope of Over-the-Counter Drug
1.2 Classification of Over-the-Counter Drug
  1.2.1 EMEA Over-the-Counter Drug Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Over-the-Counter Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Oral
  1.2.4 Topical
  1.2.5 Parenteral
1.3 EMEA Over-the-Counter Drug Market by Application/End Users
  1.3.1 EMEA Over-the-Counter Drug Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Dietary supplements
  1.3.3 Gastrointestinal drugs
  1.3.4 Pain medications
  1.3.5 Respiratory drugs
1.4 EMEA Over-the-Counter Drug Market by Region
  1.4.1 EMEA Over-the-Counter Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Over-the-Counter Drug (2012-2022)
  1.5.1 EMEA Over-the-Counter Drug Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Over-the-Counter Drug Revenue and Growth Rate (2012-2022)

2 EMEA OVER-THE-COUNTER DRUG COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Over-the-Counter Drug Market Competition by Players/Manufacturers
  2.1.1 EMEA Over-the-Counter Drug Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Over-the-Counter Drug Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Over-the-Counter Drug Sale Price by Players (2012-2017)
2.2 EMEA Over-the-Counter Drug (Volume and Value) by Type/Product Category
  2.2.1 EMEA Over-the-Counter Drug Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Over-the-Counter Drug Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Over-the-Counter Drug Sale Price by Type (2012-2017)
2.3 EMEA Over-the-Counter Drug (Volume) by Application
2.4 EMEA Over-the-Counter Drug (Volume and Value) by Region
  2.4.1 EMEA Over-the-Counter Drug Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Over-the-Counter Drug Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Over-the-Counter Drug Sales Price by Region (2012-2017)

3 EUROPE OVER-THE-COUNTER DRUG (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Over-the-Counter Drug Sales and Value (2012-2017)
  3.1.1 Europe Over-the-Counter Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Over-the-Counter Drug Revenue and Growth Rate (2012-2017)
3.2 Europe Over-the-Counter Drug Sales and Market Share by Type
3.3 Europe Over-the-Counter Drug Sales and Market Share by Application
3.4 Europe Over-the-Counter Drug Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Over-the-Counter Drug Sales Volume by Countries (2012-2017)
  3.4.2 Europe Over-the-Counter Drug Revenue by Countries (2012-2017)
  3.4.3 Germany Over-the-Counter Drug Sales and Growth Rate (2012-2017)
  3.4.4 France Over-the-Counter Drug Sales and Growth Rate (2012-2017)
  3.4.5 UK Over-the-Counter Drug Sales and Growth Rate (2012-2017)
  3.4.6 Russia Over-the-Counter Drug Sales and Growth Rate (2012-2017)
  3.4.7 Italy Over-the-Counter Drug Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Over-the-Counter Drug Sales and Growth Rate (2012-2017)

4 MIDDLE EAST OVER-THE-COUNTER DRUG (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Over-the-Counter Drug Sales and Value (2012-2017)
  4.1.1 Middle East Over-the-Counter Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Over-the-Counter Drug Revenue and Growth Rate (2012-2017)
4.2 Middle East Over-the-Counter Drug Sales and Market Share by Type
4.3 Middle East Over-the-Counter Drug Sales and Market Share by Application
4.4 Middle East Over-the-Counter Drug Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Over-the-Counter Drug Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Over-the-Counter Drug Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Over-the-Counter Drug Sales and Growth Rate (2012-2017)
  4.4.4 Israel Over-the-Counter Drug Sales and Growth Rate (2012-2017)
  4.4.5 UAE Over-the-Counter Drug Sales and Growth Rate (2012-2017)
  4.4.6 Iran Over-the-Counter Drug Sales and Growth Rate (2012-2017)

5 AFRICA OVER-THE-COUNTER DRUG (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Over-the-Counter Drug Sales and Value (2012-2017)
  5.1.1 Africa Over-the-Counter Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Over-the-Counter Drug Revenue and Growth Rate (2012-2017)
5.2 Africa Over-the-Counter Drug Sales and Market Share by Type
5.3 Africa Over-the-Counter Drug Sales and Market Share by Application
5.4 Africa Over-the-Counter Drug Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Over-the-Counter Drug Sales Volume by Countries (2012-2017)
  5.4.2 Africa Over-the-Counter Drug Revenue by Countries (2012-2017)
  5.4.3 South Africa Over-the-Counter Drug Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Over-the-Counter Drug Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Over-the-Counter Drug Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Over-the-Counter Drug Sales and Growth Rate (2012-2017)

6 EMEA OVER-THE-COUNTER DRUG MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Bayer HealthCare
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Over-the-Counter Drug Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bayer HealthCare Over-the-Counter Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GSK
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Over-the-Counter Drug Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GSK Over-the-Counter Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Johnson & Johnson
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Over-the-Counter Drug Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Johnson & Johnson Over-the-Counter Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Over-the-Counter Drug Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Over-the-Counter Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Sanofi
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Over-the-Counter Drug Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi Over-the-Counter Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Abbott
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Over-the-Counter Drug Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Abbott Over-the-Counter Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Achelios Therapeutics
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Over-the-Counter Drug Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Achelios Therapeutics Over-the-Counter Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 American Health
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Over-the-Counter Drug Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 American Health Over-the-Counter Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Amgen
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Over-the-Counter Drug Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Amgen Over-the-Counter Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 AstraZeneca
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Over-the-Counter Drug Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 AstraZeneca Over-the-Counter Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 BioGaia
6.12 Bristol-Myers Squibb
6.13 Bukwang Pharmaceutica
6.14 Chr. Hansen
6.15 Daiichi Sankyo
6.16 Dr. Reddy's Laboratories
6.17 Himalaya Drug Company
6.18 Hypermarcas

7 OVER-THE-COUNTER DRUG MANUFACTURING COST ANALYSIS

7.1 Over-the-Counter Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Over-the-Counter Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Over-the-Counter Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Over-the-Counter Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA OVER-THE-COUNTER DRUG MARKET FORECAST (2017-2022)

11.1 EMEA Over-the-Counter Drug Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Over-the-Counter Drug Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Over-the-Counter Drug Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Over-the-Counter Drug Price and Trend Forecast (2017-2022)
11.2 EMEA Over-the-Counter Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Over-the-Counter Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Over-the-Counter Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Over-the-Counter Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Over-the-Counter Drug Sales Forecast by Type (2017-2022)
11.7 EMEA Over-the-Counter Drug Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Over-the-Counter Drug
Figure EMEA Over-the-Counter Drug Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Over-the-Counter Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Product Picture
Figure Topical Product Picture
Figure Parenteral Product Picture
Figure EMEA Over-the-Counter Drug Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Over-the-Counter Drug by Application in 2016
Figure Dietary supplements Examples
Figure Gastrointestinal drugs Examples
Figure Pain medications Examples
Figure Respiratory drugs Examples
Figure EMEA Over-the-Counter Drug Market Size (Million USD) by Region (2012-2022)
Figure Europe Over-the-Counter Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Over-the-Counter Drug Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Over-the-Counter Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Over-the-Counter Drug Revenue (Million USD) Status and Forecast by Countries
Figure Africa Over-the-Counter Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Over-the-Counter Drug Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Over-the-Counter Drug Sales Volume and Growth Rate (2012-2022)
Figure EMEA Over-the-Counter Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Over-the-Counter Drug Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Over-the-Counter Drug Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Over-the-Counter Drug Sales Share by Players (2012-2017)
Figure 2016 Over-the-Counter Drug Sales Share by Players
Figure 2017 Over-the-Counter Drug Sales Share by Players
Figure EMEA Over-the-Counter Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Over-the-Counter Drug Revenue (Million USD) by Players (2012-2017)
Table EMEA Over-the-Counter Drug Revenue Share by Players (2012-2017)
Table 2016 EMEA Over-the-Counter Drug Revenue Share by Players
Table 2017 EMEA Over-the-Counter Drug Revenue Share by Players
Table EMEA Over-the-Counter Drug Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Over-the-Counter Drug Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Over-the-Counter Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Over-the-Counter Drug by Type (2012-2017)
Figure EMEA Over-the-Counter Drug Sales Market Share by Type (2012-2017)
Table EMEA Over-the-Counter Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Over-the-Counter Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Over-the-Counter Drug by Type in 2016
Table EMEA Over-the-Counter Drug Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Over-the-Counter Drug Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Over-the-Counter Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Over-the-Counter Drug by Application (2012-2017)
Figure EMEA Over-the-Counter Drug Sales Market Share by Application in 2016
Table EMEA Over-the-Counter Drug Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Over-the-Counter Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Over-the-Counter Drug by Region (2012-2017)
Figure EMEA Over-the-Counter Drug Sales Market Share in 2016
Table EMEA Over-the-Counter Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Over-the-Counter Drug Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Over-the-Counter Drug by Region (2012-2017)
Figure EMEA Over-the-Counter Drug Revenue Market Share Regions in 2016
Table EMEA Over-the-Counter Drug Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Over-the-Counter Drug Revenue and Growth Rate (2012-2017)
Table Europe Over-the-Counter Drug Sales (K Units) by Type (2012-2017)
Table Europe Over-the-Counter Drug Market Share by Type (2012-2017)
Figure Europe Over-the-Counter Drug Market Share by Type in 2016
Table Europe Over-the-Counter Drug Sales (K Units) by Application (2012-2017)
Table Europe Over-the-Counter Drug Market Share by Application (2012-2017)
Figure Europe Over-the-Counter Drug Market Share by Application in 2016
Table Europe Over-the-Counter Drug Sales (K Units) by Countries (2012-2017)
Table Europe Over-the-Counter Drug Sales Market Share by Countries (2012-2017)
Figure Europe Over-the-Counter Drug Sales Market Share by Countries (2012-2017)
Figure Europe Over-the-Counter Drug Sales Market Share by Countries in 2016
Table Europe Over-the-Counter Drug Revenue (Million USD) by Countries (2012-2017)
Table Europe Over-the-Counter Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Over-the-Counter Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Over-the-Counter Drug Revenue Market Share by Countries in 2016
Figure Germany Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure France Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure UK Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Over-the-Counter Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Over-the-Counter Drug Sales (K Units) by Type (2012-2017)
Table Middle East Over-the-Counter Drug Market Share by Type (2012-2017)
Figure Middle East Over-the-Counter Drug Market Share by Type (2012-2017)
Table Middle East Over-the-Counter Drug Sales (K Units) by Applications (2012-2017)
Table Middle East Over-the-Counter Drug Market Share by Applications (2012-2017)
Figure Middle East Over-the-Counter Drug Sales Market Share by Application in 2016
Table Middle East Over-the-Counter Drug Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Over-the-Counter Drug Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Over-the-Counter Drug Sales Volume Market Share by Countries in 2016
Table Middle East Over-the-Counter Drug Revenue (Million USD) by Countries (2012-2017)
Table Middle East Over-the-Counter Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Over-the-Counter Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Over-the-Counter Drug Revenue Market Share by Countries in 2016
Figure Saudi Arabia Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Over-the-Counter Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Over-the-Counter Drug Sales (K Units) by Type (2012-2017)
Table Africa Over-the-Counter Drug Sales Market Share by Type (2012-2017)
Figure Africa Over-the-Counter Drug Sales Market Share by Type (2012-2017)
Figure Africa Over-the-Counter Drug Sales Market Share by Type in 2016
Table Africa Over-the-Counter Drug Sales (K Units) by Application (2012-2017)
Table Africa Over-the-Counter Drug Sales Market Share by Application (2012-2017)
Figure Africa Over-the-Counter Drug Sales Market Share by Application (2012-2017)
Table Africa Over-the-Counter Drug Sales Volume (K Units) by Countries (2012-2017)
Table Africa Over-the-Counter Drug Sales Market Share by Countries (2012-2017)
Figure Africa Over-the-Counter Drug Sales Market Share by Countries (2012-2017)
Figure Africa Over-the-Counter Drug Sales Market Share by Countries in 2016
Table Africa Over-the-Counter Drug Revenue (Million USD) by Countries (2012-2017)
Table Africa Over-the-Counter Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Over-the-Counter Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Over-the-Counter Drug Revenue Market Share by Countries in 2016
Figure South Africa Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Table Bayer HealthCare Over-the-Counter Drug Basic Information List
Table Bayer HealthCare Over-the-Counter Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer HealthCare Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer HealthCare Over-the-Counter Drug Sales Market Share in EMEA (2012-2017)
Figure Bayer HealthCare Over-the-Counter Drug Revenue Market Share in EMEA (2012-2017)
Table GSK Over-the-Counter Drug Basic Information List
Table GSK Over-the-Counter Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure GSK Over-the-Counter Drug Sales Market Share in EMEA (2012-2017)
Figure GSK Over-the-Counter Drug Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Over-the-Counter Drug Basic Information List
Table Johnson & Johnson Over-the-Counter Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Over-the-Counter Drug Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Over-the-Counter Drug Revenue Market Share in EMEA (2012-2017)
Table Pfizer Over-the-Counter Drug Basic Information List
Table Pfizer Over-the-Counter Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Over-the-Counter Drug Sales Market Share in EMEA (2012-2017)
Figure Pfizer Over-the-Counter Drug Revenue Market Share in EMEA (2012-2017)
Table Sanofi Over-the-Counter Drug Basic Information List
Table Sanofi Over-the-Counter Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi Over-the-Counter Drug Sales Market Share in EMEA (2012-2017)
Figure Sanofi Over-the-Counter Drug Revenue Market Share in EMEA (2012-2017)
Table Abbott Over-the-Counter Drug Basic Information List
Table Abbott Over-the-Counter Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Over-the-Counter Drug Sales Market Share in EMEA (2012-2017)
Figure Abbott Over-the-Counter Drug Revenue Market Share in EMEA (2012-2017)
Table Achelios Therapeutics Over-the-Counter Drug Basic Information List
Table Achelios Therapeutics Over-the-Counter Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Achelios Therapeutics Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Achelios Therapeutics Over-the-Counter Drug Sales Market Share in EMEA (2012-2017)
Figure Achelios Therapeutics Over-the-Counter Drug Revenue Market Share in EMEA (2012-2017)
Table American Health Over-the-Counter Drug Basic Information List
Table American Health Over-the-Counter Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure American Health Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure American Health Over-the-Counter Drug Sales Market Share in EMEA (2012-2017)
Figure American Health Over-the-Counter Drug Revenue Market Share in EMEA (2012-2017)
Table Amgen Over-the-Counter Drug Basic Information List
Table Amgen Over-the-Counter Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Amgen Over-the-Counter Drug Sales Market Share in EMEA (2012-2017)
Figure Amgen Over-the-Counter Drug Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Over-the-Counter Drug Basic Information List
Table AstraZeneca Over-the-Counter Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca Over-the-Counter Drug Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Over-the-Counter Drug Revenue Market Share in EMEA (2012-2017)
Table BioGaia Over-the-Counter Drug Basic Information List
Table Bristol-Myers Squibb Over-the-Counter Drug Basic Information List
Table Bukwang Pharmaceutica Over-the-Counter Drug Basic Information List
Table Chr. Hansen Over-the-Counter Drug Basic Information List
Table Daiichi Sankyo Over-the-Counter Drug Basic Information List
Table Dr. Reddy's Laboratories Over-the-Counter Drug Basic Information List
Table Himalaya Drug Company Over-the-Counter Drug Basic Information List
Table Hypermarcas Over-the-Counter Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Over-the-Counter Drug
Figure Manufacturing Process Analysis of Over-the-Counter Drug
Figure Over-the-Counter Drug Industrial Chain Analysis
Table Raw Materials Sources of Over-the-Counter Drug Major Manufacturers in 2016
Table Major Buyers of Over-the-Counter Drug
Table Distributors/Traders List
Figure EMEA Over-the-Counter Drug Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Over-the-Counter Drug Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Over-the-Counter Drug Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Over-the-Counter Drug Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Over-the-Counter Drug Sales Market Share Forecast by Region (2017-2022)
Table EMEA Over-the-Counter Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Over-the-Counter Drug Revenue Market Share Forecast by Region (2017-2022)
Table Europe Over-the-Counter Drug Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Over-the-Counter Drug Sales Market Share Forecast by Countries (2017-2022)
Table Europe Over-the-Counter Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Over-the-Counter Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Over-the-Counter Drug Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Over-the-Counter Drug Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Over-the-Counter Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Over-the-Counter Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Over-the-Counter Drug Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Over-the-Counter Drug Sales Market Share Forecast by Countries (2017-2022)
Table Africa Over-the-Counter Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Over-the-Counter Drug Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Over-the-Counter Drug Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Over-the-Counter Drug Sales Market Share Forecast by Type (2017-2022)
Table EMEA Over-the-Counter Drug Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Over-the-Counter Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources